Pub Date : 2026-01-01Epub Date: 2026-03-10DOI: 10.1177/00368504261433091
Shang-Feng Tsai, Ming-Ju Wu, Cheng-Hsu Chen
ObjectiveTo compare the effectiveness, safety, and cost outcomes of brand-name febuxostat (feburic) and generic febuxostat (feuri) in patients with hyperuricemia or gout in a real-world clinical setting.MethodsWe conducted a retrospective cohort study using electronic medical records from Taichung Veterans General Hospital between November 2021 and December 2023. Adult patients with hyperuricemia or gout who initiated febuxostat therapy and had no prior urate-lowering treatment in the preceding 3 months were included. Serum uric acid levels were assessed at baseline, 3 months, and the final follow-up. Propensity score matching (1:1) was applied to balance baseline demographic, clinical, laboratory, cardiovascular, and renal characteristics. Clinical outcomes, laboratory parameters, and medication costs were compared between groups.ResultsBoth feuri and feburic were associated with significant reductions in serum uric acid levels after 3 months of treatment. At the 3-month assessment, the mean serum uric acid level was modestly lower in the feuri group (5.41 ± 2.06 mg/dL) than in the feburic group (5.75 ± 2.12 mg/dL; P = .001). At the final follow-up, serum uric acid levels remained numerically lower in the feuri group, although the difference was not statistically significant (P = .07). The feuri group was prescribed a lower final daily dose, which was associated with lower annual medication costs. The proportions of patients achieving recommended uric acid goals were similar between groups, suggesting broadly comparable clinical effectiveness in routine practice. After propensity score matching (n = 486 pairs), no significant differences were observed between groups in cardiovascular, renal, or overall safety outcomes.ConclusionsThis real-world study suggests that generic febuxostat is associated with safety outcomes comparable to those of the brand-name formulation and may be prescribed at lower doses and lower medication costs in routine clinical practice.
目的比较品牌非布司他(feburic)和非布司他(feuri)在高尿酸血症或痛风患者中的有效性、安全性和成本结果。方法采用台中退伍军人总医院2021年11月至2023年12月的电子病历进行回顾性队列研究。接受非布司他治疗且在前3个月内未接受降尿酸治疗的高尿酸血症或痛风成年患者被纳入研究。在基线、3个月和最后随访时评估血清尿酸水平。倾向评分匹配(1:1)用于平衡基线人口统计学、临床、实验室、心血管和肾脏特征。比较两组患者的临床结果、实验室参数和用药费用。结果治疗3个月后,feuri和feic均与血清尿酸水平显著降低相关。在3个月的评估中,feuric组的平均血清尿酸水平(5.41±2.06 mg/dL)略低于feuric组(5.75±2.12 mg/dL, P = .001)。在最后的随访中,尽管差异无统计学意义(P = .07),但feuri组的血清尿酸水平仍在数值上较低。feuri组的最终每日剂量较低,这与较低的年度药物费用相关。达到推荐尿酸目标的患者比例在两组之间相似,表明在常规实践中临床效果大致相当。在倾向评分匹配(n = 486对)后,两组在心血管、肾脏或总体安全结局方面没有观察到显著差异。结论:这项现实世界的研究表明,非布司他仿制药的安全性与品牌制剂相当,并且可以在常规临床实践中以更低的剂量和更低的药物成本开处方。
{"title":"A real-world retrospective cohort study comparing brand-name febuxostat (feburic) and generic febuxostat (feuri).","authors":"Shang-Feng Tsai, Ming-Ju Wu, Cheng-Hsu Chen","doi":"10.1177/00368504261433091","DOIUrl":"https://doi.org/10.1177/00368504261433091","url":null,"abstract":"<p><p>ObjectiveTo compare the effectiveness, safety, and cost outcomes of brand-name febuxostat (feburic) and generic febuxostat (feuri) in patients with hyperuricemia or gout in a real-world clinical setting.MethodsWe conducted a retrospective cohort study using electronic medical records from Taichung Veterans General Hospital between November 2021 and December 2023. Adult patients with hyperuricemia or gout who initiated febuxostat therapy and had no prior urate-lowering treatment in the preceding 3 months were included. Serum uric acid levels were assessed at baseline, 3 months, and the final follow-up. Propensity score matching (1:1) was applied to balance baseline demographic, clinical, laboratory, cardiovascular, and renal characteristics. Clinical outcomes, laboratory parameters, and medication costs were compared between groups.ResultsBoth feuri and feburic were associated with significant reductions in serum uric acid levels after 3 months of treatment. At the 3-month assessment, the mean serum uric acid level was modestly lower in the feuri group (5.41 ± 2.06 mg/dL) than in the feburic group (5.75 ± 2.12 mg/dL; <i>P</i> = .001). At the final follow-up, serum uric acid levels remained numerically lower in the feuri group, although the difference was not statistically significant (<i>P</i> = .07). The feuri group was prescribed a lower final daily dose, which was associated with lower annual medication costs. The proportions of patients achieving recommended uric acid goals were similar between groups, suggesting broadly comparable clinical effectiveness in routine practice. After propensity score matching (<i>n</i> = 486 pairs), no significant differences were observed between groups in cardiovascular, renal, or overall safety outcomes.ConclusionsThis real-world study suggests that generic febuxostat is associated with safety outcomes comparable to those of the brand-name formulation and may be prescribed at lower doses and lower medication costs in routine clinical practice.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504261433091"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147391317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-03-07DOI: 10.1177/00368504251412984
Youping Wang, Mingkai Chen, Xin Gao
Colorectal cancer remains a major global health concern, highlighting the critical importance of effective colonoscopy, whose success depends on high-quality bowel preparation. Inadequate preparation is common and leads to prolonged procedure, and missed polyps and adenomas. It is important to recognize that not all individuals can attain adequate bowel preparation through a uniform regimen. Various risk factors influencing bowel preparation quality have been reported, and different laxative regimens each present distinct advantages and limitations. Understanding these elements can help improve patient bowel preparation outcomes. This is a narrative review. This article attempts to summarize available clinical trials and evidence regarding strategies to optimize bowel preparation for individuals.
{"title":"Strategies to optimize bowel preparation quality for colonoscopy in individuals.","authors":"Youping Wang, Mingkai Chen, Xin Gao","doi":"10.1177/00368504251412984","DOIUrl":"10.1177/00368504251412984","url":null,"abstract":"<p><p>Colorectal cancer remains a major global health concern, highlighting the critical importance of effective colonoscopy, whose success depends on high-quality bowel preparation. Inadequate preparation is common and leads to prolonged procedure, and missed polyps and adenomas. It is important to recognize that not all individuals can attain adequate bowel preparation through a uniform regimen. Various risk factors influencing bowel preparation quality have been reported, and different laxative regimens each present distinct advantages and limitations. Understanding these elements can help improve patient bowel preparation outcomes. This is a narrative review. This article attempts to summarize available clinical trials and evidence regarding strategies to optimize bowel preparation for individuals.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504251412984"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12967346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-02-04DOI: 10.1177/00368504261420927
Shanshan Chen, Jing Chen, Tao Xiao
ObjectiveTo estimate the prevalence of human papillomavirus (HPV) infection among males in Jinshan District, Shanghai, China.MethodsStudy design: single-center, retrospective cross-sectional study.
Participants: 116 males aged 22-71 years from outpatient, inpatient, and routine physical examination settings.
Outcomes: overall HPV prevalence, age-specific prevalence, and genotype distribution (high-risk and low-risk).ResultsWe first describe the overall and age-specific prevalence, followed by genotype distribution and the pattern of single versus multiple infections. A total of 116 males aged 22 to 71 years old were enrolled for investigation. The overall HPV infection rate was 31.90% (37/116). The infection rates of different HPV subtypes in various age groups were listed as follows: 12% (3/25) for the 22-30 age group, 27.59% (8/29) for the 31-40 age group, 50% (18/36) for the 41-50 age group, 16.67% (3/18) for the 51-60 age group, and 62.5% (5/8) for the over 60 age group. Among the infected individuals, 27 out of 116 (23.28%) suffered from single subtype infections, while 8 individuals (6.90%) endured dual infections, and 2 individuals (1.72%) had three or more subtypes detected. High-risk HPVs accounted for 30.17%, with the highest infection rates observed in HPVs including HPV-53, HPV-58, HPV-52, HPV-16, and HPV-31. In comparison, low-risk HPVs accounted for 12.93%, with the highest infection rates seen in HPVs including HPV-6, HPV-81, and HPV-11. Apart from that, HPVs such as HPV-18, HPV-59, HPV-73, HPV-70 and HPV-83 were not detected in any of the specimens.ConclusionMales are predominantly infected with a single-subtype HPV infection. The infection rate is highest in the age group of 60 and above, while the infection rate is the lowest in the age group of 22-30 years. It is essential to formulate corresponding strategies and screening plans for the elderly over 60 years to lower or prevent the risk of HPV infection.
{"title":"Age-specific prevalence and genotype distribution of male HPV infection in Jinshan District, Shanghai, China: A single-center cross-sectional study.","authors":"Shanshan Chen, Jing Chen, Tao Xiao","doi":"10.1177/00368504261420927","DOIUrl":"10.1177/00368504261420927","url":null,"abstract":"<p><p>ObjectiveTo estimate the prevalence of human papillomavirus (HPV) infection among males in Jinshan District, Shanghai, China.MethodsStudy design: single-center, retrospective cross-sectional study.</p><p><strong>Setting: </strong>Tinglin Hospital, Jinshan District, Shanghai, China.</p><p><strong>Participants: </strong>116 males aged 22-71 years from outpatient, inpatient, and routine physical examination settings.</p><p><strong>Outcomes: </strong>overall HPV prevalence, age-specific prevalence, and genotype distribution (high-risk and low-risk).ResultsWe first describe the overall and age-specific prevalence, followed by genotype distribution and the pattern of single versus multiple infections. A total of 116 males aged 22 to 71 years old were enrolled for investigation. The overall HPV infection rate was 31.90% (37/116). The infection rates of different HPV subtypes in various age groups were listed as follows: 12% (3/25) for the 22-30 age group, 27.59% (8/29) for the 31-40 age group, 50% (18/36) for the 41-50 age group, 16.67% (3/18) for the 51-60 age group, and 62.5% (5/8) for the over 60 age group. Among the infected individuals, 27 out of 116 (23.28%) suffered from single subtype infections, while 8 individuals (6.90%) endured dual infections, and 2 individuals (1.72%) had three or more subtypes detected. High-risk HPVs accounted for 30.17%, with the highest infection rates observed in HPVs including HPV-53, HPV-58, HPV-52, HPV-16, and HPV-31. In comparison, low-risk HPVs accounted for 12.93%, with the highest infection rates seen in HPVs including HPV-6, HPV-81, and HPV-11. Apart from that, HPVs such as HPV-18, HPV-59, HPV-73, HPV-70 and HPV-83 were not detected in any of the specimens.ConclusionMales are predominantly infected with a single-subtype HPV infection. The infection rate is highest in the age group of 60 and above, while the infection rate is the lowest in the age group of 22-30 years. It is essential to formulate corresponding strategies and screening plans for the elderly over 60 years to lower or prevent the risk of HPV infection.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504261420927"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12873103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-01-14DOI: 10.1177/00368504251395189
Maureen Juga, Farai Nyabadza
When the demand for public health care increases, governments often prioritize citizens over foreign nationals. In South Africa, limited resources and socio-economic inequalities pose unique challenges to epidemic control. The overcrowding and increasing demand for public healthcare have led to protests by some community groups, which have led to the denial of healthcare to migrants. Denying treatment to some infected individuals has the propensity to lead to an increase in the size of an epidemic. We introduce a novel epidemiological model that incorporates health care denial as a dynamic factor influencing the transmission of COVID-19. It incorporates healthcare denial as a key parameter influencing the progression and recovery rates of infections. The study presents a novel framework for understanding the intersection of healthcare access denial and the transmission dynamics of COVID-19. While much of the existing literature has focused on the direct effects of healthcare interventions on pandemic control, this research uniquely emphasizes the role that restricted access to healthcare services, whether due to policy decisions, resource shortages, or system inefficiencies, can exacerbate the spread of infectious diseases. The treatment class of the model is partitioned to account for individuals denied treatment at public healthcare facilities. Analytical results establish conditions for the existence and stability of both disease-free and endemic equilibria, with the basic reproduction number R0 explicitly derived to quantify transmission potential under varying healthcare access scenarios. Sensitivity analysis reveals that increasing denial of care can significantly elevate R0, resulting in higher infection peaks, prolonged epidemic duration and greater cumulative mortality. Numerical simulations further illustrate the non-linear relationship between treatment accessibility and outbreak severity. The findings highlight that equitable healthcare provision is not only a public health necessity but also a critical determinant for reducing the COVID-19 burden. Policy implications stress the integration of inclusive healthcare strategies to ensure epidemic resilience and minimize transmission risks, especially in vulnerable populations. Strategies that will accommodate every infected person who goes to the hospital for treatment should be adopted to reduce the disease burden.
{"title":"The potential impact of public health care denial on the transmission dynamics of COVID-19 in South Africa.","authors":"Maureen Juga, Farai Nyabadza","doi":"10.1177/00368504251395189","DOIUrl":"10.1177/00368504251395189","url":null,"abstract":"<p><p>When the demand for public health care increases, governments often prioritize citizens over foreign nationals. In South Africa, limited resources and socio-economic inequalities pose unique challenges to epidemic control. The overcrowding and increasing demand for public healthcare have led to protests by some community groups, which have led to the denial of healthcare to migrants. Denying treatment to some infected individuals has the propensity to lead to an increase in the size of an epidemic. We introduce a novel epidemiological model that incorporates health care denial as a dynamic factor influencing the transmission of COVID-19. It incorporates healthcare denial as a key parameter influencing the progression and recovery rates of infections. The study presents a novel framework for understanding the intersection of healthcare access denial and the transmission dynamics of COVID-19. While much of the existing literature has focused on the direct effects of healthcare interventions on pandemic control, this research uniquely emphasizes the role that restricted access to healthcare services, whether due to policy decisions, resource shortages, or system inefficiencies, can exacerbate the spread of infectious diseases. The treatment class of the model is partitioned to account for individuals denied treatment at public healthcare facilities. Analytical results establish conditions for the existence and stability of both disease-free and endemic equilibria, with the basic reproduction number <i>R</i><sub>0</sub> explicitly derived to quantify transmission potential under varying healthcare access scenarios. Sensitivity analysis reveals that increasing denial of care can significantly elevate <i>R</i><sub>0</sub>, resulting in higher infection peaks, prolonged epidemic duration and greater cumulative mortality. Numerical simulations further illustrate the non-linear relationship between treatment accessibility and outbreak severity. The findings highlight that equitable healthcare provision is not only a public health necessity but also a critical determinant for reducing the COVID-19 burden. Policy implications stress the integration of inclusive healthcare strategies to ensure epidemic resilience and minimize transmission risks, especially in vulnerable populations. Strategies that will accommodate every infected person who goes to the hospital for treatment should be adopted to reduce the disease burden.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504251395189"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12804654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-02-15DOI: 10.1177/00368504261420611
Guang Tu, Zhonglan Cai, Guofeng Zhu, Min Huang
IntroductionHeparin-induced thrombocytopenia (HIT) is a severe complication of heparin treatment, characterized by low platelet counts and heightened thrombotic risk. Blood urea nitrogen (BUN), which serves as an indicator of both renal function and illness severity, has been associated with poor outcomes in different contexts. However, its association with mortality in HIT remains poorly understood. Our study aimed to explore this relationship in critically ill patients with HIT.MethodsThis study was a retrospective cohort analysis utilizing the MIMIC-IV 3.1 database from 2008 to 2019. Patients with HIT were pinpointed through ICD codes. Those without BUN data or whose intensive care unit (ICU) admission was not their first were excluded. The main outcome measured was all-cause mortality, evaluated at multiple time points. The associations were examined using multivariate Cox regression models and Kaplan-Meier survival analysis.ResultsThe research encompassed 246 individuals with HIT (average age 66.2 years, 54.9% male). BUN levels showed a significant association with all-cause mortality during the hospital stay (HR 1.01, 95% CI 1.01-1.02, p = 0.001), within 30 days (HR 1.01, 95% CI 1.01-1.02, p < 0.001), within 90 days (HR 1.01, 95% CI 1.01-1.02, p < 0.001), and within 365 days (HR 1.01, 95% CI 1.01-1.02, p < 0.001). Quartile analysis revealed that the highest BUN quartile (Q4) was associated with the greatest mortality risk compared to the lowest quartile (Q1) at all time points. Kaplan-Meier and restricted cubic spline analyses corroborated these results, indicating a linear relationship between BUN and mortality.ConclusionElevated BUN levels were significantly associated with higher mortality rates among HIT patients in the ICU. Monitoring BUN levels may help identify patients at greater risk and inform clinical choices. Further research is warranted to elucidate the underlying mechanisms and possible treatments.
肝素诱导的血小板减少症(HIT)是肝素治疗的严重并发症,其特点是血小板计数低和血栓形成风险增加。血尿素氮(BUN)作为肾功能和疾病严重程度的指标,在不同情况下与不良预后相关。然而,其与HIT死亡率的关系仍然知之甚少。我们的研究旨在探讨重症HIT患者的这种关系。方法采用2008 - 2019年MIMIC-IV 3.1数据库进行回顾性队列分析。通过ICD代码确定HIT患者。没有BUN数据或首次入住重症监护病房(ICU)的患者被排除在外。测量的主要结果是在多个时间点评估的全因死亡率。使用多变量Cox回归模型和Kaplan-Meier生存分析检验相关性。结果共纳入246例HIT患者,平均年龄66.2岁,男性占54.9%。BUN水平与住院期间(HR 1.01, 95% CI 1.01-1.02, p = 0.001)和30天内(HR 1.01, 95% CI 1.01-1.02, p p p p)的全因死亡率显著相关
{"title":"BUN and mortality in patients with heparin-induced thrombocytopenia: A retrospective cohort study.","authors":"Guang Tu, Zhonglan Cai, Guofeng Zhu, Min Huang","doi":"10.1177/00368504261420611","DOIUrl":"10.1177/00368504261420611","url":null,"abstract":"<p><p>IntroductionHeparin-induced thrombocytopenia (HIT) is a severe complication of heparin treatment, characterized by low platelet counts and heightened thrombotic risk. Blood urea nitrogen (BUN), which serves as an indicator of both renal function and illness severity, has been associated with poor outcomes in different contexts. However, its association with mortality in HIT remains poorly understood. Our study aimed to explore this relationship in critically ill patients with HIT.MethodsThis study was a retrospective cohort analysis utilizing the MIMIC-IV 3.1 database from 2008 to 2019. Patients with HIT were pinpointed through ICD codes. Those without BUN data or whose intensive care unit (ICU) admission was not their first were excluded. The main outcome measured was all-cause mortality, evaluated at multiple time points. The associations were examined using multivariate Cox regression models and Kaplan-Meier survival analysis.ResultsThe research encompassed 246 individuals with HIT (average age 66.2 years, 54.9% male). BUN levels showed a significant association with all-cause mortality during the hospital stay (HR 1.01, 95% CI 1.01-1.02, <i>p</i> = 0.001), within 30 days (HR 1.01, 95% CI 1.01-1.02, <i>p</i> < 0.001), within 90 days (HR 1.01, 95% CI 1.01-1.02, <i>p</i> < 0.001), and within 365 days (HR 1.01, 95% CI 1.01-1.02, <i>p</i> < 0.001). Quartile analysis revealed that the highest BUN quartile (Q4) was associated with the greatest mortality risk compared to the lowest quartile (Q1) at all time points. Kaplan-Meier and restricted cubic spline analyses corroborated these results, indicating a linear relationship between BUN and mortality.ConclusionElevated BUN levels were significantly associated with higher mortality rates among HIT patients in the ICU. Monitoring BUN levels may help identify patients at greater risk and inform clinical choices. Further research is warranted to elucidate the underlying mechanisms and possible treatments.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504261420611"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12909767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146203906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-01-16DOI: 10.1177/00368504251412578
Thapthep Saowarot, Napadon Tangjaturonrasme
ObjectiveThe use of aspirin in patients undergoing open tracheostomy is an issue for which there is still no clear conclusion. This uncertainty leads surgeons to make decisions based on the risks and benefits of continuing versus discontinuing aspirin. Therefore, this study aims to investigate complications related to aspirin use. The primary outcome was bleeding complications, while other complications were secondary outcomes.MethodsThis was a retrospective study compiling data from patients who underwent open tracheostomy at the Department of Otolaryngology, Faculty of Medicine, Chulalongkorn university and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, between January 2019 and December 2023. Demographic data, medical conditions, indications for tracheostomy, surgeon characteristics, operative time, aspirin use status, and complications were reviewed.ResultsThere were 47 patients in total in this study: 15 patients in the aspirin continuation group and 32 patients in the aspirin discontinuation group. In the aspirin continuation group, there were no major or minor bleeding events. In the discontinuation group, there were two cases of major bleeding and two cases of minor bleeding (an incidence of 6.3% for each), although the differences observed were not statistically significant. There were no other complications that showed statistically significant differences between the two groups.ConclusionThis study has shown that low-dose aspirin (81 mg) does not increase the risk of bleeding or other complications in patients who undergo open tracheostomy. These results support that the continuation of aspirin may be safe in patients undergoing this procedure.
{"title":"Comparison of complications in open tracheostomy in patients taking low-dose aspirin.","authors":"Thapthep Saowarot, Napadon Tangjaturonrasme","doi":"10.1177/00368504251412578","DOIUrl":"10.1177/00368504251412578","url":null,"abstract":"<p><p>ObjectiveThe use of aspirin in patients undergoing open tracheostomy is an issue for which there is still no clear conclusion. This uncertainty leads surgeons to make decisions based on the risks and benefits of continuing versus discontinuing aspirin. Therefore, this study aims to investigate complications related to aspirin use. The primary outcome was bleeding complications, while other complications were secondary outcomes.MethodsThis was a retrospective study compiling data from patients who underwent open tracheostomy at the Department of Otolaryngology, Faculty of Medicine, Chulalongkorn university and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, between January 2019 and December 2023. Demographic data, medical conditions, indications for tracheostomy, surgeon characteristics, operative time, aspirin use status, and complications were reviewed.ResultsThere were 47 patients in total in this study: 15 patients in the aspirin continuation group and 32 patients in the aspirin discontinuation group. In the aspirin continuation group, there were no major or minor bleeding events. In the discontinuation group, there were two cases of major bleeding and two cases of minor bleeding (an incidence of 6.3% for each), although the differences observed were not statistically significant. There were no other complications that showed statistically significant differences between the two groups.ConclusionThis study has shown that low-dose aspirin (81 mg) does not increase the risk of bleeding or other complications in patients who undergo open tracheostomy. These results support that the continuation of aspirin may be safe in patients undergoing this procedure.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504251412578"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811579/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-02-11DOI: 10.1177/00368504261423340
Rami Mosleh, Yazun Jarrar, Shurouq Ghalib Qadous, Mustafa Ghanim
ObjectivesPolypharmacy, the concurrent use of multiple medications, presents significant challenges and risks in modern healthcare systems, particularly among older individuals and those with chronic diseases. This study aimed to investigate the prevalence and determinants of potential drug-drug interactions (pDDIs) among older adults at Jerusalem, Gaza Strip, and the West Bank of Palestine. This study serves as a baseline assessment before the October 2023 Palestine crisis, which led to extensive forced displacement.MethodsThis cross-sectional study examined the prescribed medications for 403 participants, conducted between May 2023 and August 2023, 2 months prior to the invasion of Gaza. This study served as a baseline evaluation of the potential pDDIs before the 7 October 2023 of Palestine crisis. Participants recruited using simple random sampling technique from medical records' lists of patients. They were interviewed at various pharmacies and hospitals across Jerusalem, the Gaza Strip, and the West Bank of Palestine using an online questionnaire created via Google Forms. Descriptive, Univariate and multivariate analyses, and Chi-square tests were carried-out by SPSS v21.ResultsThe study revealed a high prevalence of pDDIs among the Palestinian population, with a substantial proportion of participants experiencing moderate to major interactions. Participants receiving a higher number of medications were significantly more likely to experience major pDDIs. Additionally, marital status was a significant factor associated with major pDDIs, with married individuals being more likely to experience major interactions compared to non-married individuals. Regional differences were also observed, with participants residing in the northern region of the West Bank more likely to experience moderate pDDIs. Moreover, participants diagnosed with dyslipidemia and diabetes mellitus were significantly more prone to moderate pDDIs.ConclusionsThese findings emphasize the interaction of clinical and demographic factors in influencing the risk of pDDIs among participant patients in Palestine. Healthcare providers should consider these factors when prescribing medications and designing interventions to reduce the risks associated with polypharmacy.
{"title":"Polypharmacy and potential drug-drug interactions among older patients: A cross-sectional baseline study pre-2023 Palestine crisis.","authors":"Rami Mosleh, Yazun Jarrar, Shurouq Ghalib Qadous, Mustafa Ghanim","doi":"10.1177/00368504261423340","DOIUrl":"10.1177/00368504261423340","url":null,"abstract":"<p><p>ObjectivesPolypharmacy, the concurrent use of multiple medications, presents significant challenges and risks in modern healthcare systems, particularly among older individuals and those with chronic diseases. This study aimed to investigate the prevalence and determinants of potential drug-drug interactions (pDDIs) among older adults at Jerusalem, Gaza Strip, and the West Bank of Palestine. This study serves as a baseline assessment before the October 2023 Palestine crisis, which led to extensive forced displacement.MethodsThis cross-sectional study examined the prescribed medications for 403 participants, conducted between May 2023 and August 2023, 2 months prior to the invasion of Gaza. This study served as a baseline evaluation of the potential pDDIs before the 7 October 2023 of Palestine crisis. Participants recruited using simple random sampling technique from medical records' lists of patients. They were interviewed at various pharmacies and hospitals across Jerusalem, the Gaza Strip, and the West Bank of Palestine using an online questionnaire created via Google Forms. Descriptive, Univariate and multivariate analyses, and Chi-square tests were carried-out by SPSS v21.ResultsThe study revealed a high prevalence of pDDIs among the Palestinian population, with a substantial proportion of participants experiencing moderate to major interactions. Participants receiving a higher number of medications were significantly more likely to experience major pDDIs. Additionally, marital status was a significant factor associated with major pDDIs, with married individuals being more likely to experience major interactions compared to non-married individuals. Regional differences were also observed, with participants residing in the northern region of the West Bank more likely to experience moderate pDDIs. Moreover, participants diagnosed with dyslipidemia and diabetes mellitus were significantly more prone to moderate pDDIs.ConclusionsThese findings emphasize the interaction of clinical and demographic factors in influencing the risk of pDDIs among participant patients in Palestine. Healthcare providers should consider these factors when prescribing medications and designing interventions to reduce the risks associated with polypharmacy.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504261423340"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146167930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-01-09DOI: 10.1177/00368504251413441
Shuaixian Tao, Yurong Zhao, Jidong Wang, Shaofeng Xu, Jifa Hou, Baoxin Li, Qiang Wang, Rong Ren, Zhonglin Lu, Zhaowei Li
ObjectiveTo evaluate the clinical efficacy of the direct posterior approach (DPA) with seagull-shaped plate fixation for treating posterior wall acetabular fractures.MethodsA retrospective cohort study of 17 patients (8 male, 9 female) with posterior wall acetabular fractures treated with DPA seagull-shaped plate fixation was conducted. Postoperative pelvic X-ray imaging and computed tomography were performed, and the quality of acetabular reduction was evaluated using the Matta score. The Merle d'Aubigné & Bone score, as modified by Matta, was used to assess hip joint function.ResultsThe mean ± standard deviation surgical incision length, operating time, and intraoperative blood loss were 9.7 ± 0.6 cm, 48.7 ± 9.1 min, and 235.3 ± 65.6 mL, respectively. According to the Matta score, 11 patients achieved excellent reduction quality, and six had good reduction quality, resulting in a 100% combined excellent or good reduction rate. All patients had good fracture healing, with a healing time of 9.7 ± 1.6 weeks. The modified Merle d'Aubigné & Bone score was 17.0 ± 1.6, with 11, 4, 2, and 0 patients rated as excellent, good, fair, and poor, respectively, yielding an 88.2% excellent or good outcome rate. Postoperative complications included fat liquefaction in one patient and deep vein thrombosis in the lower limbs of two patients, with an overall complication rate of 17.6%.ConclusionsDPA with seagull-shaped plate fixation provides satisfactory clinical outcomes for posterior wall acetabular fractures, improving patients' living ability and quality of life.
目的评价直接后路海鸥型钢板内固定治疗髋臼后壁骨折的临床疗效。方法对17例髋臼后壁骨折患者(男8例,女9例)采用DPA海鸥形钢板内固定进行回顾性队列研究。术后行盆腔x线成像和计算机断层扫描,使用Matta评分评估髋臼复位质量。经Matta修改的Merle d' aubign & Bone评分用于评估髋关节功能。结果手术切口长度、手术时间和术中出血量的平均±标准差分别为9.7±0.6 cm、48.7±9.1 min和235.3±65.6 mL。根据Matta评分,11例患者复位质量优良,6例复位质量良好,综合优良率为100%。所有患者骨折愈合良好,愈合时间为9.7±1.6周。改良的Merle d' aubign & Bone评分为17.0±1.6,分别有11例、4例、2例和0例患者被评为优、良、一般和差,优良率为88.2%。术后并发症1例脂肪液化,2例下肢深静脉血栓形成,总并发症发生率为17.6%。结论sdpa联合海鸥形钢板内固定治疗髋臼后壁骨折临床效果满意,提高了患者的生活能力和生活质量。
{"title":"Treatment of posterior wall acetabular fractures via the direct posterior approach using a seagull-shaped plate: A retrospective cohort study.","authors":"Shuaixian Tao, Yurong Zhao, Jidong Wang, Shaofeng Xu, Jifa Hou, Baoxin Li, Qiang Wang, Rong Ren, Zhonglin Lu, Zhaowei Li","doi":"10.1177/00368504251413441","DOIUrl":"10.1177/00368504251413441","url":null,"abstract":"<p><p>ObjectiveTo evaluate the clinical efficacy of the direct posterior approach (DPA) with seagull-shaped plate fixation for treating posterior wall acetabular fractures.MethodsA retrospective cohort study of 17 patients (8 male, 9 female) with posterior wall acetabular fractures treated with DPA seagull-shaped plate fixation was conducted. Postoperative pelvic X-ray imaging and computed tomography were performed, and the quality of acetabular reduction was evaluated using the Matta score. The Merle d'Aubigné & Bone score, as modified by Matta, was used to assess hip joint function.ResultsThe mean ± standard deviation surgical incision length, operating time, and intraoperative blood loss were 9.7 ± 0.6 cm, 48.7 ± 9.1 min, and 235.3 ± 65.6 mL, respectively. According to the Matta score, 11 patients achieved excellent reduction quality, and six had good reduction quality, resulting in a 100% combined excellent or good reduction rate. All patients had good fracture healing, with a healing time of 9.7 ± 1.6 weeks. The modified Merle d'Aubigné & Bone score was 17.0 ± 1.6, with 11, 4, 2, and 0 patients rated as excellent, good, fair, and poor, respectively, yielding an 88.2% excellent or good outcome rate. Postoperative complications included fat liquefaction in one patient and deep vein thrombosis in the lower limbs of two patients, with an overall complication rate of 17.6%.ConclusionsDPA with seagull-shaped plate fixation provides satisfactory clinical outcomes for posterior wall acetabular fractures, improving patients' living ability and quality of life.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504251413441"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12789403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145946666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-02-19DOI: 10.1177/00368504261425535
Anke Shi, Haotian Lu, Jing Zhao, Mingshuai Ai, Jieqiong Yu, Tianpeng Hu, Shengtao Yan
BackgroundSepsis, caused by a dysregulated host response to infection, is a life-threatening condition linked to nearly one-fifth of deaths worldwide. As a biomarker of myocardial stress, N-terminal pro B-type natriuretic peptide (NT-proBNP) has gained attention for its potential association with clinical outcomes in sepsis patients. This study investigated its association with short- and long-term mortality in sepsis.MethodsThis retrospective observational cohort study utilized data from the Medical Information Mart for Intensive Care IV database. Sepsis patients on their first intensive care unit admission with NT-proBNP measured within 24 h were categorized into four groups based on their natural log-transformed levels. The primary endpoint was 30-day all-cause mortality (ACM), with secondary endpoints of 90-day and 1-year ACM. Cox models, Kaplan-Meier curves, restricted cubic splines (RCS), and subgroup analyses were performed to assess the relationship between log(NT-proBNP) and 30-day, 90-day, and 1-year ACM.ResultsThe study cohort consisted of 1237 patients, with 54.41% male. The 30-day, 90-day, and 1-year ACM rates were 27.41%, 29.99%, and 31.69%, respectively. Multivariate Cox analysis showed that log(NT-proBNP) was independently associated with higher risks of 30-day ACM (hazard ratio[HR] 1.12 [95% confidence interval (CI) 1.03-1.22]; P = 0.01), 90-day ACM (HR 1.12 [95% CI 1.03-1.22]; P = 0.005), and 1-year ACM (HR 1.11 [95% CI 1.03-1.20]; P = 0.007). These associations remained robust in sensitivity analyses. The RCS curves demonstrated a linear increase in ACM risk as log(NT-proBNP) levels rose. Subgroup analyses confirmed these associations across different patient groups.ConclusionElevated log(NT-proBNP) in critically ill sepsis patients are significantly and independently associated with higher 30-day, 90-day, and 1-year ACM, suggesting that NT-proBNP may serve as a valuable risk marker for both short- and long-term mortality in this population.
败血症是由宿主对感染反应失调引起的,是一种危及生命的疾病,与全球近五分之一的死亡有关。作为心肌应激的生物标志物,n端前b型利钠肽(NT-proBNP)因其与败血症患者临床结局的潜在关联而受到关注。本研究调查了其与脓毒症的短期和长期死亡率的关系。方法本回顾性观察队列研究利用重症监护医学信息市场IV数据库的数据。首次入住重症监护室的脓毒症患者在24小时内测量NT-proBNP,根据其自然对数转化水平将其分为四组。主要终点为30天全因死亡率(ACM),次要终点为90天和1年ACM。采用Cox模型、Kaplan-Meier曲线、限制性三次样条(RCS)和亚组分析来评估log(NT-proBNP)与30天、90天和1年ACM之间的关系。结果本研究共纳入1237例患者,男性占54.41%。30天、90天和1年的ACM利率分别为27.41%、29.99%和31.69%。多因素Cox分析显示,log(NT-proBNP)与30天ACM的高风险独立相关(风险比[HR] 1.12[95%可信区间(CI) 1.03-1.22];P = 0.01), 90天的ACM (HR 1.12 (95% CI 1.03 - -1.22); P = 0.005),和1年期ACM (HR 1.11 (95% CI 1.03 - -1.20); P = 0.007)。在敏感性分析中,这些关联仍然很强。RCS曲线显示,随着log(NT-proBNP)水平的升高,ACM风险呈线性增加。亚组分析证实了不同患者组之间的这些关联。结论:危重症脓毒症患者的log升高(NT-proBNP)与30天、90天和1年的ACM升高有显著且独立的相关性,表明NT-proBNP可能是该人群短期和长期死亡率的有价值的风险标志物。
{"title":"Association between N-terminal pro B-type natriuretic peptide and short- and long-term all-cause mortality in critically ill patients with sepsis: A retrospective study based on the Medical Information Mart for Intensive Care IV database.","authors":"Anke Shi, Haotian Lu, Jing Zhao, Mingshuai Ai, Jieqiong Yu, Tianpeng Hu, Shengtao Yan","doi":"10.1177/00368504261425535","DOIUrl":"10.1177/00368504261425535","url":null,"abstract":"<p><p>BackgroundSepsis, caused by a dysregulated host response to infection, is a life-threatening condition linked to nearly one-fifth of deaths worldwide. As a biomarker of myocardial stress, N-terminal pro B-type natriuretic peptide (NT-proBNP) has gained attention for its potential association with clinical outcomes in sepsis patients. This study investigated its association with short- and long-term mortality in sepsis.MethodsThis retrospective observational cohort study utilized data from the Medical Information Mart for Intensive Care IV database. Sepsis patients on their first intensive care unit admission with NT-proBNP measured within 24 h were categorized into four groups based on their natural log-transformed levels. The primary endpoint was 30-day all-cause mortality (ACM), with secondary endpoints of 90-day and 1-year ACM. Cox models, Kaplan-Meier curves, restricted cubic splines (RCS), and subgroup analyses were performed to assess the relationship between log(NT-proBNP) and 30-day, 90-day, and 1-year ACM.ResultsThe study cohort consisted of 1237 patients, with 54.41% male. The 30-day, 90-day, and 1-year ACM rates were 27.41%, 29.99%, and 31.69%, respectively. Multivariate Cox analysis showed that log(NT-proBNP) was independently associated with higher risks of 30-day ACM (hazard ratio[HR] 1.12 [95% confidence interval (CI) 1.03-1.22]; <i>P</i> = 0.01), 90-day ACM (HR 1.12 [95% CI 1.03-1.22]; <i>P</i> = 0.005), and 1-year ACM (HR 1.11 [95% CI 1.03-1.20]; <i>P</i> = 0.007). These associations remained robust in sensitivity analyses. The RCS curves demonstrated a linear increase in ACM risk as log(NT-proBNP) levels rose. Subgroup analyses confirmed these associations across different patient groups.ConclusionElevated log(NT-proBNP) in critically ill sepsis patients are significantly and independently associated with higher 30-day, 90-day, and 1-year ACM, suggesting that NT-proBNP may serve as a valuable risk marker for both short- and long-term mortality in this population.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"109 1","pages":"368504261425535"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12924985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146229833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ObjectivesGrassland net primary productivity (NPP) in the Ili River Basin Grasslands, as Earth's largest terrestrial ecosystem, are crucial for global carbon cycling and ecological stability. Clarifying the spatiotemporal patterns and driving factors of grassland NPP is key to optimizing conservation strategies and enhancing productivity.MethodsUsing MODIS data (2000-2022) and the CASA model, this study estimated grassland NPP in the Ili River Basin, and explored its dynamic characteristics and responses to climate and human activities through trend analysis, correlation analysis, and the Hurst index.Results(1) NPP increased annually by 0.14% from 2000 to 2020, but decreased by 15.4% from 2020 to 2022, with an overall 12.95% decline over 23 years; extreme climates in 2008, 2014, and 2021 caused NPP to drop by 27.24%, 28.01%, and 21.31%, respectively, compared to the previous years. (2) High-NPP areas were concentrated in eastern mountainous regions (Nileke, Zhaosu, Tekes, etc.), while low-NPP areas were distributed in central urban zones and high-altitude regions, showing an "east-high-west-low" pattern. (3) Temperature was the main climatic driver (affecting 91,253 km²); human activities led to NPP decline in 55.94% of the area (far exceeding the 2.81% where NPP increased). (4) The Hurst index projected that 79.5% of the area would shift from decline to increase, 8% would continue to decline, and 9.81% would reverse from increase to decline.ConclusionsNPP showed a downward trend from 2000 to 2022 but is expected to rise significantly in the future, providing references for conservation efforts.
{"title":"Analysis of the spatiotemporal dynamics of natural grassland productivity and its influencing factors in the Ili River Basin of Xinjiang over the past 23 years.","authors":"Shujing Lin, Chengchi Zhang, Xiuzhi Ma, Xinqiao Li, Zhichao Hu, Yanan Ma, Minyi Wang","doi":"10.1177/00368504251397434","DOIUrl":"10.1177/00368504251397434","url":null,"abstract":"<p><p>ObjectivesGrassland net primary productivity (NPP) in the Ili River Basin Grasslands, as Earth's largest terrestrial ecosystem, are crucial for global carbon cycling and ecological stability. Clarifying the spatiotemporal patterns and driving factors of grassland NPP is key to optimizing conservation strategies and enhancing productivity.MethodsUsing MODIS data (2000-2022) and the CASA model, this study estimated grassland NPP in the Ili River Basin, and explored its dynamic characteristics and responses to climate and human activities through trend analysis, correlation analysis, and the Hurst index.Results(1) NPP increased annually by 0.14% from 2000 to 2020, but decreased by 15.4% from 2020 to 2022, with an overall 12.95% decline over 23 years; extreme climates in 2008, 2014, and 2021 caused NPP to drop by 27.24%, 28.01%, and 21.31%, respectively, compared to the previous years. (2) High-NPP areas were concentrated in eastern mountainous regions (Nileke, Zhaosu, Tekes, etc.), while low-NPP areas were distributed in central urban zones and high-altitude regions, showing an \"east-high-west-low\" pattern. (3) Temperature was the main climatic driver (affecting 91,253 km²); human activities led to NPP decline in 55.94% of the area (far exceeding the 2.81% where NPP increased). (4) The Hurst index projected that 79.5% of the area would shift from decline to increase, 8% would continue to decline, and 9.81% would reverse from increase to decline.ConclusionsNPP showed a downward trend from 2000 to 2022 but is expected to rise significantly in the future, providing references for conservation efforts.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"108 4","pages":"368504251397434"},"PeriodicalIF":2.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12623619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145544154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}